The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...
Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at ...
The new mRNA vaccine provides more protection than the standard flu shot.
Moderna received FDA approval for its new mRNA-based flu shot for older adults after months of regulatory questioning.
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust ...
The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...
On August 5, Health Secretary Robert F. Kennedy Jr. announced that the Department of Health and Human Services would terminate almost $500 million in mRNA vaccine development grants and contracts, ...
Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to create and grow tissue. And in the event of an immune response, different ...
Add Yahoo as a preferred source to see more of our stories on Google. But now, the U.S. federal government is slashing its investments in mRNA vaccines — a move that will immediately impact 22 ...
The shot, made by Moderna, will be available for this year's upcoming flu season.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results